Susquehanna International Group
IRWD icon

Susquehanna International Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Susquehanna International Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$933K Buy
265,800
+252,100
+1,840% +$1.03M ﹤0.01% 8053
2025
Q4 		$46.2K Buy
+13,700
New +$35.6K ﹤0.01% 11778
2024
Q3 		– Sell
-12,200
Closed -$79.5K – 12483
2024
Q2 		$79.5K Sell
12,200
-255,000
-95% -$1.8M ﹤0.01% 11177
2024
Q1 		$2.33M Buy
267,200
+240,400
+897% +$2.92M ﹤0.01% 4993
2023
Q4 		$307K Buy
+26,800
New +$265K ﹤0.01% 9793
2022
Q1 		– Sell
-26,000
Closed -$303K – 13483
2021
Q4 		$303K Sell
26,000
-3,600
-12% -$44.2K ﹤0.01% 10478
2021
Q3 		$387K Sell
29,600
-7,700
-21% -$99.5K ﹤0.01% 10010
2021
Q2 		$480K Sell
37,300
-46,300
-55% -$530K ﹤0.01% 9698
2021
Q1 		$935K Buy
83,600
+66,700
+395% +$705K ﹤0.01% 7921
2020
Q4 		$192K Sell
16,900
-18,100
-52% -$198K ﹤0.01% 10081
2020
Q3 		$315K Sell
35,000
-31,500
-47% -$313K ﹤0.01% 8601
2020
Q2 		$686K Buy
66,500
+25,900
+64% +$265K ﹤0.01% 6693
2020
Q1 		$410K Buy
+40,600
New +$477K ﹤0.01% 7355
2019
Q4 		– Sell
-15,000
Closed -$129K – 10150
2019
Q3 		$129K Sell
15,000
-5,000
-25% -$48.6K ﹤0.01% 9419
2019
Q2 		$219K Sell
20,000
-46,625
-70% -$522K ﹤0.01% 8954
2019
Q1 		$755K Sell
66,625
-27,104
-29% -$303K ﹤0.01% 5539
2018
Q4 		$813K Buy
93,729
+34,984
+60% +$401K ﹤0.01% 5080
2018
Q3 		$908K Buy
58,745
+29,014
+98% +$459K ﹤0.01% 5415
2018
Q2 		$476K Sell
29,731
-12,895
-30% -$191K ﹤0.01% 6887
2018
Q1 		$551K Buy
+42,626
New +$531K ﹤0.01% 6429
2017
Q4 		– Sell
-198,085
Closed -$2.62M – 9570
2017
Q3 		$2.62M Buy
198,085
+157,489
+388% +$2.17M ﹤0.01% 3441
2017
Q2 		$642K Buy
40,596
+22,447
+124% +$326K ﹤0.01% 6164
2017
Q1 		$259K Sell
18,149
-27,820
-61% -$380K ﹤0.01% 7594
2016
Q4 		$589K Sell
45,969
-478
-1% -$6.04K ﹤0.01% 6640
2016
Q3 		$618K Buy
+46,447
New +$543K ﹤0.01% 5675
2016
Q2 		– Sell
-54,805
Closed -$502K – 8919
2016
Q1 		$502K Sell
54,805
-39,163
-42% -$323K ﹤0.01% 6391
2015
Q4 		$912K Sell
93,968
-40,118
-30% -$388K ﹤0.01% 5602
2015
Q3 		$1.17M Buy
134,086
+61,133
+84% +$570K ﹤0.01% 5381
2015
Q2 		$737K Buy
72,953
+51,222
+236% +$595K ﹤0.01% 6840
2015
Q1 		$291K Sell
21,731
-1,910
-8% -$25.1K ﹤0.01% 8030
2014
Q4 		$303K Sell
23,641
-248,830
-91% -$2.85M ﹤0.01% 8117
2014
Q3 		$2.96M Buy
272,471
+241,069
+768% +$2.76M ﹤0.01% 3922
2014
Q2 		$403K Sell
31,402
-41,074
-57% -$447K ﹤0.01% 7872
2014
Q1 		$748K Sell
72,476
-116,654
-62% -$1.31M ﹤0.01% 6038
2013
Q4 		$1.84M Buy
189,130
+89,192
+89% +$801K ﹤0.01% 4423
2013
Q3 		$992K Buy
99,938
+86,565
+647% +$849K ﹤0.01% 5290
2013
Q2 		$111K Buy
+13,373
New +$162K ﹤0.01% 7750

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group's IRWD Position: Q1 2026 in Review

Susquehanna International Group increased its Ironwood Pharmaceuticals (IRWD) stake by 228% in Q1 2026, buying an estimated $4.19M and bringing the position to 1,472,157 shares worth $5.17M. The position accounts for ﹤0.01% of the portfolio, ranked #4159.

Susquehanna International Group first reported a position in IRWD in Q3 2013 and has held it in 43 quarters since. The position peaked at $7.01M in Q1 2015. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Susquehanna International Group held 1,472,157 shares of Ironwood Pharmaceuticals worth $5.17M as of Q1 2026.
  • Susquehanna International Group bought 1,023,358 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $4.19M.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4159 holding.
  • Susquehanna International Group first reported a position in Ironwood Pharmaceuticals in Q3 2013 and has held it in 43 quarters since.
  • Susquehanna International Group's Ironwood Pharmaceuticals position peaked at $7.01M in Q1 2015.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.